William E Gillanders

12PUBLICATIONS
151CO-AUTHORS
Predictive and prognostic markersNanomedicineCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 10, 2026
Automating neoantigen selection for personalized cancer vaccine design.

|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.

|Apr 17, 2026
Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.

|Apr 15, 2026
mRNA vaccines engage unconventional pathways in CD8<sup>+</sup> T cell priming.

|Feb 06, 2026
Neoadjuvant Endocrine Treatment plus Mammaglobin-A DNA Vaccine Induces Antitumor Immune Responses in the Primary Tumor and Peripheral Blood of Patients with Breast Cancer: Insights from a Phase Ib Clinical Trial.

Rashmi Mishra, Foluso Ademuyiwa, Yilin Yang

|Nov 14, 2024
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.

Xiuli Zhang, S Peter Goedegebuure, Michael Y Chen

Pageof 2

Frequent Collaborators

6 joint publications

John M Herndon

4 joint publications

Foluso O Ademuyiwa

4 joint publications

Feng Chen

4 joint publications

Li Ding